Covid-19 and Neurology
Keywords:
COVID-19, Coronavirus 2019, SARS-CoV-2, Neurologic disease, NeurologyAbstract
The coronavirus 2019 (COVID-19) infection initially affects the respiratory system. However, nervous system involvement lately becomes a significant feature of COVID-19 infection. The neurologic manifestations can be direct and indirect viral effects or just the non-specific complications from critical illness. The prevalence of stroke in patients with COVID-19 is higher than in other viral infections. COVID-19 patients with stroke have a high mortality rate. Central nervous system involvement with alteration of consciousness commonly occurs in hospitalized patients with COVID-19. As well as any other viruses, COVID-19 infection may likely be antecedent to Guillain Barre Syndrome. COVID-19 vaccination may cause neurological complications.
Downloads
References
Lee Y, Min P, Lee S, Kim SW. Prevalence and Duration of Acute Loss of Smell or Taste in COVID-19 Patients. J Korean Med Sci. 2020;35(18):174.
Anand P, Zhou L, Bhadelia N, Hamer DH, Greer DM, Cervantes-Arslanian AM. Neurologic findings among inpatients with COVID-19 at a safety-net US hospital. Neurology: Clinical Practice. 2021;11(2):83-91.
Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683-690.
Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. Lancet Neurol. 2020;19(9):767-783.
Merkler AE, Parikh NS, Mir S, et al. Risk of Ischemic Stroke in Patients With Coronavirus Disease 2019 (COVID-19) vs Patients With Influenza. JAMA Neurol. 2020;77(11):1366.
Siddiqi HK, Libby P, Ridker PM. COVID-19 - A vascular disease. Trends Cardiovasc Med. 2021;31(1):1-5.
Rho HJ, Sangha NS. Abstract 12: Feasibility of Monitoring Covid-19 Related Stroke Patients Across a 14 Hospital Stroke System of Care. Stroke. 2021;52(1):12.
Nogueira RG, Qureshi MM, Abdalkader M, et al. Global Impact of COVID-19 on Stroke Care and Intravenous Thrombolysis. Neurology. 2021. doi: 10.1212/WNL.0000000000011885.
Avula A, Nalleballe K, Narula N, et al. COVID-19 presenting as stroke. Brain Behav Immun. 2020;87:115-119.
Beyrouti R, Adams ME, Benjamin L, et al. Characteristics of ischaemic stroke associated with COVID-19. J Neurol Neurosurg Psychiatry. 2020;91(8):889-891.
Baldini T, Asioli GM, Romoli M, et al. Cerebral venous thrombosis and severe acute respiratory syndrome coronavirus-2 infection: A systematic review and meta-analysis. Eur J Neurol. 2021.
Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417-1418.
Paniz-Mondolfi A, Bryce C, Grimes Z, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol. 2020;92(7):699-702.
Bhatia R, Pedapati R, Komakula S, Srivastava MVP, Vishnubhatla S, Khuranac D. Stroke in Coronavirus Disease 2019: A Systematic Review. Journal of Stroke. 2020;22(3):324-335.
Friedlich D, Newman T, Bricker S. Impact of the COVID-19 Pandemic on Stroke Epidemiology and Clinical Stroke Practice in the US. Journal of Stroke and Cerebro-vascular Diseases. 2021;30(4):105639.
Muengtaweepongsa S, Hunghok W, Harnirattisai T. Poor Recognition of Prompted Treatment Seeking Even with Good Knowledge of Stroke Warning Signs Contribute to Delayed Arrival of Acute Ischemic Stroke Patients in Thailand. J Stroke Cerebrovasc Dis. 2014;23(5):948-952.
Morelli N, Rota E, Terracciano C, et al. The Baffling Case of Ischemic Stroke Disappearance from the Casualty Department in the COVID-19 Era. European Neurology. 2020;83(2):213-215.
Kansagra AP, Goyal MS, Hamilton S, Albers GW. Collateral Effect of Covid-19 on Stroke Evaluation in the United States. New England Journal of Medicine. 2020;383(4):400-401.
Solomon IH, Normandin E, Bhattacharyya S, et al. Neuropathological Features of Covid-19. N Engl J Med. 2020;383(10):989-992.
Venkatesan A, Tunkel AR, Bloch KC, et al. Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis. 2013;57(8):1114-1128.
Pilotto A, Masciocchi S, Volonghi I, et al. The clinical spectrum of encephalitis in COVID-19 disease: the ENCOVID multicentre study. medRxiv. 2020. doi: 10.1101/ 2020.06.19. 20133991.
Efe IE, Aydin OU, Alabulut A, Celik O, Aydin K. COVID-19-Associated Encephalitis Mimicking Glial Tumor. World Neurosurg. 2020;140:46-48.
Huang YH, Jiang D, Huang JT. SARS-CoV-2 Detected in Cerebrospinal Fluid by PCR in a Case of COVID-19 Encephalitis. Brain Behav Immun. 2020;87:149.
Moriguchi T, Harii N, Goto J, et al. A first case of meningitis/encephalitis associated with SARS-Coronavirus-2. Int J Infect Dis. 2020;94:55-58.
Frontera JA, Sabadia S, Lalchan R, et al. A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City. Neurology. 2021;96(4): 575-586.
Karvigh SA, Vahabizad F, Mirhadi MS, Banihashemi G, Montazeri M. COVID-19-related refractory status epilepticus with the presence of SARS-CoV-2 (RNA) in the CSF: a case report. Neurol Sci. 2021.
Zhao H, Shen D, Zhou H, Liu J, Chen S. Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? The Lancet Neurology. 2020;19(5):383-384.
Gutierrez-Ortiz C, Mendez-Guerrero A, Rodrigo-Rey S, et al. Miller Fisher syndrome and polyneuritis cranialis in COVID-19. Neurology. 2020;95(5):601-605.
Shouman K, Vanichkachorn G, Cheshire WP, et al. Autonomic dysfunction following COVID-19 infection: an early experience. Clinical Autonomic Research. 2021.
Restivo DA, Centonze D, Alesina A, Marchese-Ragona R. Myasthenia Gravis Associated With SARS-CoV-2 Infection. Annals of Internal Medicine. 2020;173(12):1027-1028.
Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the Nervous System. Cell. 2020;183(1):16-27.
Hoffman LA, Vilensky JA. Encephalitis lethargica: 100 years after the epidemic. Brain. 2017;140(8):2246-2251.
Zhu FC, Guan XH, Li YH, et al. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet. 2020;396(10249):479-488.
Schultz NH, Sorvoll IH, Michelsen AE, et al. Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination. N Engl J Med. 2021.
Bayas A, Menacher M, Christ M, Behrens L, Rank A, Naumann M. Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination. The Lancet. 2021.
Taquet M, Husain M, Geddes JR, Luciano S, Harrison PJ. Cerebral venous thrombosis: a retrospective cohort study of 513,284 confirmed COVID-19 cases and a comparison with 489,871 people receiving a COVID-19 mRNA vaccine. 2021.
Greinacher A, Thiele T, Warkentin TE, Weisser K, Kyrle P, Eichinger S. A Prothrombotic Thrombocytopenic Disorder Resembling Heparin-Induced Thrombocytopenia Following Coronavirus-19 Vaccination. 2021.
McMurtry CM. Managing immunization stress-related response: A contributor to sustaining trust in vaccines. Canada Communicable Disease Report. 2020:210-218.
Gold MS, Macdonald NE, McMurtry CM, et al. Immunization stress-related response - Redefining immunization anxiety-related reaction as an adverse event following immunization. Vaccine. 2020;38(14):3015-3020.
Lerthattasilp T, Kosulwit L, Phanasathit M, et al. Psychological impacts on patients with COVID-19 in a Thai field hospital. Arc Clin Psychiatr. 2020;47(6):215-217.
Ha K-M. A lesson learned from the MERS outbreak in South Korea in 2015. Journal of Hospital Infection. 2016;92(3):232-234.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
